What this study is
This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.
What's being tested
- Atricure CryoSPHERE MAX Probe
Intervention · DEVICE
Patients will be treated intra-operatively with Atricure CryoSPHERE MAX Probe to 2 intercostal spaces above and below the thoracotomy incision for 1 minutes for each application during their double lung transplant procedure.
Study details
- Sponsor
- University of California, Los Angeles
- Conditions
- Post-operative Pain Management
- Enrolling
- 148 people
- Starts
- 2025-12-16
- Est. completion
- 2027-11-24
- Design
- Double-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Adults ≥18 years of age
- Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision
You can't join if
- Multi-organ transplant recipients
- Redo lung transplant recipients
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (3)
3 openUniversity of California Los Angeles
Los Angeles, California, United States
- Steven Stokes · Contact310-794-206-7436sstokes@mednet.ucla.edu
- Jenny Lester, MPH · Contact310-794-9728jlester@mednet.ucla.edu
- Abbas Ardehali, MD · Principal investigator
RecruitingUniversity of California San Francisco
San Francisco, California, United States
Not yet recruitingBaylor University
Waco, Texas, United States
Not yet recruiting
Study team
Sponsor
University of California, Los Angeles
Study ID IRB-24-6029
Principal investigator
Abbas Ardehali, MD
University of California, Los Angeles
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.